<ul><li>HealthCare Global Enterprises Limited (HCG) has partnered with Accenture to transform cancer research with generative AI and deep learning.</li><li>The collaboration aims to accelerate precision medicine development by analyzing patient data and enabling earlier detection and more effective treatments for various cancers.</li><li>The partnership combines HCG's expertise with Accenture's capabilities in AI, machine learning, and quantum computing to drive innovation in drug discovery, biomarker identification, and treatment pathway development.</li><li>The program focuses on identifying molecular signatures for lung adenocarcinoma and head and neck cancers and aims to improve understanding of cancer development, origins, symptoms, and therapy outcomes.</li></ul>

HCG, Accenture Partner to Transform Cancer Research with AI

Discover more